On Jun. 11, 2020, Regeneron announced that Science had accepted for publication two papers describing the creation of…
On Jun. 10, 2020, researchers funded by the National Institutes of Health (NIH) launched an effort to evaluate…
On Jun. 10, 2020, the FDA issued an emergency use authorization (EUA) to Illumina for the first COVID-19…
On Jun. 10, 2020, Washington University School of Medicine in St. Louis reported they had developed a mouse…
On Jun. 10, 2020, OraSure Technologies announced it had been awarded a $629,217 contract from the Biomedical Advanced…
On Jun. 10, 2020, Catalent announced that it had signed an agreement with Spicona to develop a virus-like…
On Jun. 10, 2020, RedHill Biopharma announced it had submitted a Clinical Trial Application (CTA) with the Ministry…
On Jun. 9, 2020, Quidel announced it had received an amended Emergency Use Authorization (EUA) from the FDA,…
On Jun. 9, 2020, a Scripps research analysis of public datasets on asymptomatic infections, an extraordinary percentage of…
On Jun. 9, 2020, OpGen announced preliminary data from an investigator initiated collaboration with Karolinska Institutet, Stockholm, Sweden,…
On Jun. 9, 2020, Immunic announced receipt of regulatory allowance from the FDA to initiate its phase 2,…
On Jun. 9, 2020, Aegis Sciences announced that it was registered and approved to provide public health reporting…
On Jun. 8, 2020, FibroGen announced the initiation of an open-label, randomized, parallel-arm study investigating the efficacy and…
On Jun. 8, 2020, Eli Lilly announced its partner Junshi Biosciences had dosed the first healthy volunteer in…
On Jun. 8, 2020, OraSure Technologies announced that Phosphorus Diagnostics, a leader in diagnostic and bioinformatic solutions for…
On Jun. 5, 2020, the Alberta Precision Laboratories (APL) COVID-19 Biorepository was announced to ensure researchers have the…
On Jun. 5, 2020, early data from a clinical study suggested that blocking the Bruton tyrosine kinase (BTK)…
On Jun. 5, 2020, results were published in Science Immunology showed that Calquence (acalabrutinib), a Brutonï¾’s tyrosine kinase…
On Jun. 5, 2020, the Chief Investigators of the randomised evaluation of COVid-19 thERapY (RECOVERY) trial on hydroxychloroquine…
On Jun. 5, 2020, Sorrento announced it had completed a preclinical batch of the STI-4398 (COVIDTRAP) protein and…
On Jun. 5, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma, announced it had expanded its patient enrollment…
On Jun. 5, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, CSL and The University of Queensland (UQ)…
On Jun. 4, 2020, world leaders pledged an additional US$ 8.8 billion for Gavi, the Vaccine Alliance, far…
On Jun. 4, 2020, the U.S. Department of Health and Human Services (HHS) announced new Guidance that specified…
On Jun. 4, 2020, the Bill & Melinda Gates Foundation announced a five-year, US$1.6 billion commitment to Gavi,…
On Jun. 4, 2020, AstraZeneca announced the next steps in its commitment to broad and equitable global access…
On Jun. 4, 2020, data from the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the…
On Jun. 4, 2020, Novavax announced that the company had been awarded a contract by the U.S. Department…
On Jun. 4, 2020, INOVIO and Seoul National University Hospital announced a partnership to start a Phase 1/2…
On Jun. 4, 2020, iBio announced it had initiatied preclinical immunization studies for its second COVID-19 vaccine platform….